On Mar. 11, 2020, the La Jolla Institute for Immunology (LJI) and the J. Craig Venter Institute announced that a team of researchers had provided the first analysis of potential targets for effective immune responses against the novel coronavirus.

The researchers used existing data from known coronaviruses to predict which parts of SARS-CoV-2 are capable of activating the human immune system. The study was published in Host, Cell and Microbe.